US Patent Issued to Xilio Development on April 22 for "Tumor-specific cleavable linkers" (Massachusetts Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,120, issued on April 22, was assigned to Xilio Development Inc. (Waltham, Mass.).

"Tumor-specific cleavable linkers" was invented by Raphael Rozenfeld (Swampscott, Mass.), Ugur Eskiocak (Somerville, Mass.), Huawei Qiu (Westborough, Mass.), Parker Johnson (Allston, Mass.), Kurt Allen Jenkins (Weymouth, Mass.), Magali Pederzoli-Ribeil (Cambridge, Mass.), Dheeraj Singh Tomar (Dorchester, Mass.) and Rebekah Kay O'Donnell (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides tumor-specific cleavable linkers and their use in drugs and prodrugs for delivering therapeutics to a tumor cell environment. The present di...